关键词: COVID-19 inflammatory bowel disease integrative review motivational interviewing patient engagement telemedicine therapeutic adherence

来  源:   DOI:10.3390/healthcare12121210   PDF(Pubmed)

Abstract:
Aims and Objectives: This review aims to analyze the effectiveness of motivational interviewing (MI) in enhancing therapeutic adherence and compliance in adult patients with inflammatory bowel disease (IBD), especially considering the disruptions caused by the COVID-19 pandemic. Background: IBD, which includes conditions such as ulcerative colitis and Crohn\'s disease, affects over 10 million people globally. It significantly impacts both physical and psychological well-being, leading to challenges in therapeutic adherence. Only 25-47% of patients with IBD adequately follow prescribed treatments. Design and Methods: An integrative methodology that combines qualitative and quantitative research was utilized, following a 7-step framework. This framework encompasses identifying the research question, devising a search strategy, performing a critical appraisal, summarizing findings, extracting data, conducting an analysis, and drawing conclusions. Results: Poor adherence to therapy among patients with IBD can exacerbate disease progression and result in complications. MI has been identified as a promising approach to improving both adherence and treatment outcomes. Studies, including those predating the COVID-19 pandemic, have demonstrated MI\'s effectiveness in enhancing adherence among patients with IBD. Conclusions: MI shows promise in enhancing adherence among adult patients with IBD. Although initial results are promising, additional research is needed to thoroughly understand its effectiveness across various clinical contexts. Relevance to Clinical Practice: The findings underscore the potential of MI as an integral component of IBD treatment strategies, suggesting that its implementation could enhance patient-provider interactions and lead to better overall health outcomes.
摘要:
目的和目标:这篇综述旨在分析动机性访谈(MI)在提高成人炎症性肠病(IBD)患者治疗依从性和依从性方面的有效性。特别是考虑到COVID-19大流行造成的干扰。背景:IBD,包括溃疡性结肠炎和克罗恩病,影响全球超过1000万人。它显著影响身体和心理健康,导致治疗依从性方面的挑战。只有25-47%的IBD患者充分遵循处方治疗。设计和方法:采用了定性和定量研究相结合的综合方法,遵循一个7步框架。这个框架包括确定研究问题,设计搜索策略,进行批判性评估,总结调查结果,提取数据,进行分析,并得出结论。结果:IBD患者对治疗的依从性差会加剧疾病进展并导致并发症。MI已被确定为改善依从性和治疗结果的有希望的方法。研究,包括那些早于COVID-19大流行的人,已证明MI在提高IBD患者依从性方面的有效性。结论:MI有望提高成年IBD患者的依从性。尽管初步结果很有希望,需要更多的研究来彻底了解其在各种临床环境中的有效性.与临床实践的相关性:研究结果强调了MI作为IBD治疗策略不可或缺的组成部分的潜力。这表明其实施可以增强患者与提供者的互动,并带来更好的整体健康结果。
公众号